240 related articles for article (PubMed ID: 35665023)
1. Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Myers J; Li Y; Chambers MS
J Immunother Precis Oncol; 2021 Nov; 4(4):196-207. PubMed ID: 35665023
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.
Yanni A; Bouland C; Monteiro R; Rodriguez A; Loeb I; Javadian R; Dequanter D
J Int Soc Prev Community Dent; 2022; 12(5):564-570. PubMed ID: 36532328
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
[TBL] [Abstract][Full Text] [Related]
4. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
5. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Antiresorptive Drug Holidays on Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis.
Aboalela AA; Farook FF; Alqahtani AS; Almousa MA; Alanazi RT; Almohammadi DS
Cureus; 2022 Oct; 14(10):e30485. PubMed ID: 36415385
[TBL] [Abstract][Full Text] [Related]
7. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review.
Ottesen C; Schiodt M; Gotfredsen K
Heliyon; 2020 Apr; 6(4):e03795. PubMed ID: 32373730
[TBL] [Abstract][Full Text] [Related]
9. Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients-A Systematic Review.
Rosales HD; Garcia Guevara H; Requejo S; Jensen MD; Acero J; Olate S
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835951
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R; Woolley J; Patel G; Calasans-Maia MD; Yates J
Br J Oral Maxillofac Surg; 2022 Feb; 60(2):e216-e230. PubMed ID: 35115201
[TBL] [Abstract][Full Text] [Related]
11. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
12. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
13. Emerging antiresorptive medications and their potential implications for dental surgeries.
Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D
J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242
[TBL] [Abstract][Full Text] [Related]
14. The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
J Res Med Sci; 2021; 26():23. PubMed ID: 34221052
[TBL] [Abstract][Full Text] [Related]
15. Is it safe to place implants in patients at risk of MRONJ?
Owen B; Bradley H
Evid Based Dent; 2021 Jan; 22(3):108-109. PubMed ID: 34561663
[TBL] [Abstract][Full Text] [Related]
16. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
[TBL] [Abstract][Full Text] [Related]
17. Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center.
Hajeri S; Alturkistany Y
Saudi Dent J; 2022 Sep; 34(6):479-484. PubMed ID: 36092518
[TBL] [Abstract][Full Text] [Related]
18. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
19. Medication-related osteonecrosis of the jaw: Case series and literature review.
Kimathi D; Butt F; Guthua S; Waweru W
Clin Case Rep; 2024 Apr; 12(4):e8788. PubMed ID: 38645603
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
